ACORN CAPITAL ADVISORS, LLC TRVI Holdings History
ACORN CAPITAL ADVISORS, LLC's Trevi Therapeutics Inc Holding Summary
As of 2025-03-31, ACORN CAPITAL ADVISORS, LLC held 2.14 Mil shares of Trevi Therapeutics Inc(TRVI), totaling $13.49 Mil. This investment constitutes 9% of their stock portfolio, and ACORN CAPITAL ADVISORS, LLC now holds 2.11% of the outstanding Trevi Therapeutics Inc(TRVI) stock.
The initial trade took place in 2024Q4. And since then ACORN CAPITAL ADVISORS, LLC has made 1 purchases of TRVI, at an average price of $3.31, for a total of 2.14 Mil shares. Based on historical transaction data and TRVI's current price of $6.86, ACORN CAPITAL ADVISORS, LLC's estimated gain on his TRVI holdings is $7.62 Mil, reflecting a 107.55% gain to date.
ACORN CAPITAL ADVISORS, LLC TRVI ($6.86) Holding Chart
ACORN CAPITAL ADVISORS, LLC TRVI ($6.86) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
